Nutex Health, Inc. (NUTX)
USD 129.67
(-1.79%)
USD 129.67
(-1.79%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 319.13 Million USD | 2.48% |
| 2022 | 311.42 Million USD | 53.36% |
| 2021 | 203.06 Million USD | 25.98% |
| 2020 | 161.18 Million USD | 25.55% |
| 2019 | 128.38 Million USD | 6494.94% |
| 2018 | 1.94 Million USD | 102.84% |
| 2017 | 959.78 Thousand USD | -84.96% |
| 2016 | 6.38 Million USD | 5.0% |
| 2015 | 6.07 Million USD | 0.0% |
| 2011 | 470.27 Thousand USD | 33.74% |
| 2010 | 351.61 Thousand USD | 0.0% |
| 2009 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 340.38 Million USD | 4.97% |
| 2024 Q1 | 324.27 Million USD | 1.61% |
| 2023 Q4 | 319.13 Million USD | -14.83% |
| 2023 FY | 319.13 Million USD | 2.48% |
| 2023 Q2 | 328 Million USD | 2.32% |
| 2023 Q1 | 320.55 Million USD | 2.93% |
| 2023 Q3 | 374.72 Million USD | 14.24% |
| 2022 Q2 | 305.37 Million USD | 2623.97% |
| 2022 Q4 | 311.42 Million USD | 3.12% |
| 2022 FY | 311.42 Million USD | 53.36% |
| 2022 Q1 | 11.21 Million USD | -94.48% |
| 2022 Q3 | 301.98 Million USD | -1.11% |
| 2021 Q2 | 10.09 Million USD | 4.36% |
| 2021 Q3 | 159.04 Million USD | 1475.76% |
| 2021 Q4 | 203.06 Million USD | 27.68% |
| 2021 Q1 | 9.67 Million USD | -94.0% |
| 2021 FY | 203.06 Million USD | 25.98% |
| 2020 Q3 | 1.59 Million USD | -59.54% |
| 2020 FY | 161.18 Million USD | 25.55% |
| 2020 Q4 | 161.18 Million USD | 9997.23% |
| 2020 Q2 | 3.94 Million USD | -2.78% |
| 2020 Q1 | 4.05 Million USD | -16.05% |
| 2019 Q4 | 4.83 Million USD | 230.01% |
| 2019 FY | 128.38 Million USD | 6494.94% |
| 2019 Q1 | 1.22 Million USD | -11.73% |
| 2019 Q2 | 1.32 Million USD | 8.36% |
| 2019 Q3 | 1.46 Million USD | 10.54% |
| 2018 Q2 | 1.11 Million USD | 5.24% |
| 2018 Q1 | 1.06 Million USD | 10.6% |
| 2018 FY | 1.94 Million USD | 102.84% |
| 2018 Q4 | 1.38 Million USD | 14.14% |
| 2018 Q3 | 1.21 Million USD | 8.65% |
| 2017 Q2 | 622.32 Thousand USD | 0.0% |
| 2017 Q4 | 959.78 Thousand USD | 30.75% |
| 2017 FY | 959.78 Thousand USD | -84.96% |
| 2017 Q3 | 734.03 Thousand USD | 17.95% |
| 2016 FY | 6.38 Million USD | 5.0% |
| 2015 FY | 6.07 Million USD | 0.0% |
| 2011 Q3 | 256.38 Thousand USD | -9.42% |
| 2011 Q1 | 265.39 Thousand USD | -24.52% |
| 2011 FY | 470.27 Thousand USD | 33.74% |
| 2011 Q2 | 283.05 Thousand USD | 6.65% |
| 2011 Q4 | 470.27 Thousand USD | 83.42% |
| 2010 Q3 | 178.6 Thousand USD | -52.02% |
| 2010 Q4 | 351.61 Thousand USD | 96.87% |
| 2010 Q2 | 372.23 Thousand USD | 108.41% |
| 2010 Q1 | 178.6 Thousand USD | 79.63% |
| 2010 FY | 351.61 Thousand USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | 99.43 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Augmedix, Inc. | 43.39 Million USD | -635.497% |
| OneMedNet Corporation | 13.32 Million USD | -2295.462% |
| Minerva Surgical, Inc. | 51.71 Million USD | -517.064% |
| CareCloud, Inc. | 37.79 Million USD | -744.351% |
| CareCloud, Inc. | 37.79 Million USD | -744.351% |
| HealthEquity, Inc. | 1.2 Billion USD | 73.438% |
| iCoreConnect Inc. | 11.24 Million USD | -2738.728% |
| Progyny, Inc. | 203.19 Million USD | -57.064% |
| Renalytix Plc | 15.82 Million USD | -1916.551% |
| Schrödinger, Inc. | 254.39 Million USD | -25.449% |
| Simulations Plus, Inc. | 14.2 Million USD | -2146.195% |
| SOPHiA GENETICS SA | 54.71 Million USD | -483.287% |
| Omnicell, Inc. | 1.03 Billion USD | 69.252% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 93.837% |
| Streamline Health Solutions, Inc. | 22.92 Million USD | -1292.041% |
| Inovalon Holdings, Inc. | 1.26 Billion USD | 74.725% |
| Ontrak, Inc. | 5.57 Million USD | -5624.473% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 98.731% |
| Sharecare, Inc. | 125.56 Million USD | -154.163% |
| Aclarion, Inc. | 3.18 Million USD | -9911.371% |
| CareMax, Inc. | 561.85 Million USD | 43.199% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -173016.024% |
| Forian Inc. | 33.19 Million USD | -861.368% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -173016.024% |
| HeartBeam, Inc. | 1.19 Million USD | -26628.592% |
| GeneDx Holdings Corp. | 245.65 Million USD | -29.913% |
| SCWorx Corp. | 2.42 Million USD | -13061.657% |
| Definitive Healthcare Corp. | 626.72 Million USD | 49.078% |
| 10x Genomics, Inc. | 224.1 Million USD | -42.409% |
| Zhongchao Inc. | 3.37 Million USD | -9346.261% |
| Accolade, Inc. | 342.68 Million USD | 6.871% |
| MSP Recovery, Inc. | 1.74 Billion USD | 81.668% |
| R1 RCM Inc. | 2.2 Billion USD | 85.551% |
| Spok Holdings, Inc. | 63.91 Million USD | -399.334% |
| Privia Health Group, Inc. | 392.51 Million USD | 18.693% |
| EUDA Health Holdings Limited | 8.79 Million USD | -3529.701% |
| TruBridge, Inc. | 247.8 Million USD | -28.787% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 93.837% |
| Sharecare, Inc. | 125.56 Million USD | -154.163% |
| Health Catalyst, Inc. | 334.89 Million USD | 4.705% |
| GoodRx Holdings, Inc. | 826.84 Million USD | 61.403% |
| Premier, Inc. | 1.46 Billion USD | 78.236% |
| HealthStream, Inc. | 159.19 Million USD | -100.477% |
| Certara, Inc. | 516.29 Million USD | 38.187% |
| GeneDx Holdings Corp. | 245.65 Million USD | -29.913% |
| Ontrak, Inc. | 5.57 Million USD | -5624.473% |
| SHL Telemedicine Ltd. | 36.58 Million USD | -772.246% |
| CareCloud, Inc. | 37.79 Million USD | -744.351% |
| EUDA Health Holdings Limited | 8.79 Million USD | -3529.701% |
| HeartBeam, Inc. | 1.19 Million USD | -26628.592% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -115513.877% |
| CareMax, Inc. | 561.85 Million USD | 43.199% |
| Healthcare Triangle, Inc. | 9.51 Million USD | -3255.477% |
| National Research Corporation | 73.48 Million USD | -334.31% |
| Aclarion, Inc. | 3.18 Million USD | -9911.371% |
| OptimizeRx Corporation | 56.82 Million USD | -461.66% |